CG
CALA

Cutler Group’s Calithera Biosciences, Inc CALA Stock Holding History

Cutler Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100
Closed -$13K – 5146
2018
Q1 		$13K Sell
100
-150
-60% -$23.4K ﹤0.01% 2613
2017
Q4 		$17K Sell
250
-15
-6% -$3.84K ﹤0.01% 2727
2017
Q3 		$3K Sell
265
-945
-78% -$298K ﹤0.01% 4920
2017
Q2 		$11K Buy
1,210
+100
+9% +$26.7K ﹤0.01% 4106
2017
Q1 		$18K Buy
+1,110
New +$192K ﹤0.01% 3463
2016
Q1 		– Sell
-165
Closed -$3K – 7444
2015
Q4 		$3K Buy
+165
New +$24.7K ﹤0.01% 5431

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cutler Group's CALA Position: Q2 2018 in Review

Cutler Group held its Calithera Biosciences, Inc (CALA) position steady in Q2 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5145.

Cutler Group first reported a position in CALA in Q4 2015 and has held it in 7 quarters since. The position peaked at $265K in Q2 2017. 90 funds tracked by Wall St. Rank hold CALA as of Q2 2018.

  • Cutler Group held 0 shares of Calithera Biosciences, Inc worth $0 as of Q2 2018.
  • Cutler Group left its Calithera Biosciences, Inc share count unchanged in Q2 2018.
  • Calithera Biosciences, Inc made up ﹤0.01% of Cutler Group's portfolio in Q2 2018, its #5145 holding.
  • Cutler Group first reported a position in Calithera Biosciences, Inc in Q4 2015 and has held it in 7 quarters since.
  • Cutler Group's Calithera Biosciences, Inc position peaked at $265K in Q2 2017.
  • 90 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2018.

Based on Cutler Group's 13F filing for Q2 2018, filed 10 Aug 2018.